GenIP Plc has unveiled Invention Validator, a new product that tests whether breakthrough technologies are ready for market adoption.
The premium service commands fees exceeding $12,000 – much higher than the firm’s existing offering.
Investors will hope that the new offering will help drive GenIP’s growth and will be pleased to see the first sale of the product to a South African research university. They’re using it to evaluate an agricultural biotechnology innovation—testing real farmer reactions before commercialisation.
The two-step process combines technical assessment with hard market data. First, GenIP evaluates IP strength and market potential. Then comes the crucial part: structured questionnaires distributed to actual end-users. In this case, farmers answer questions about pricing, barriers, and whether they’d actually buy the technology.
GenIP analyses the responses alongside technical evaluations to deliver strategic recommendations on commercialisation approach, pricing strategy, and partnership priorities.
The methodology isn’t limited to agriculture. Medical devices, renewable energy systems, advanced materials, environmental monitoring tools, and digital health platforms could all benefit from the validation framework.
Interest is already building. Three Chilean universities have expressed interest, with one reviewing a proposal. GenIP plans broader outreach to corporations and research organisations.
The service leverages AI-powered automation to keep consulting overheads low while maintaining strategic depth—designed as a high-margin, replicable offering built on GenIP’s proprietary technology ranking system.
“This new product marks an important milestone in GenIP’s evolution from delivering standalone reports to becoming an embedded partner in our clients’ commercialization decisions,” said Melissa Cruz, CEO of GenIP.
“Many technologies fail because research teams have to choose between slow, expensive market studies or risky assumptions about user adoption. Invention Validator bridges that gap by delivering fast, actionable insights by pairing AI driven analysis with real user feedback.
“Invention Validator is strategically significant because it builds directly on our Invention Evaluator foundation. Organizations start with our core report, then progress naturally to Invention Validator to test real-world adoption. This progression from evaluation to validation and through to execution, creates the opportunity for recurring revenues to drive our growth strategy.
“Universities have been asking for this capability and we have demonstrated this demand through its inaugural engagement. As we scale Invention Validator, we are building the high-value, repeatable client journeys that unlock sustained revenue growth.”
Invention Validator’s launch follows GenIP’s recently announced commercial strategy to deliver a suite of AI-powered products for organisations commercialising innovations.